{{Rsnum
|rsid=35882952
|Gene=EPHB2
|Chromosome=1
|position=22863060
|Orientation=plus
|GMAF=0.0004591
|Gene_s=EPHB2,MIR4253
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{omim
|id=600997
|rsnum=35882952
|variant=0002
}}

{{ClinVar
|rsid=35882952
|Reversed=0
|FwdREF=G
|FwdALT=T
|REF=G
|ALT=T
|RSPOS=22863060
|CHROM=1
|GMAF=0.0005
|dbSNPBuildID=126
|SSR=0
|SAO=1
|VP=0x050060040a0504051e110100
|GENEINFO=EPHB2:2048; MIR4253:100422914
|GENE_NAME=EPHB2; MIR4253
|GENE_ID=2048; 100422914
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000001.11:g.22863060G>T
|CLNORIGIN=1
|CLNSIG=5
|Tags=PM;NSM;REF;R3;ASP;VLD;HD;GNO;KGPhase1;KGPilot123;KGPROD;OTHERKG;LSD;OM
|CAF=0.9995; 0.0004591
|CLNACC=RCV000009059.1
|CLNDBN=Prostate cancer, progression and metastasis of
|CLNSRC=ClinVar; OMIM Allelic Variant
|CLNSRCID=NM_004442.6:c.835G>T; NR_036214.1:n.167C>A; 600997.0002
|COMMON=0
|Disease=Prostate cancer
}}

{{GET Evidence
|gene=EPHB2
|aa_change=Ala279Ser
|aa_change_short=A279S
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs35882952
|overall_frequency_n=63
|overall_frequency_d=10758
|overall_frequency=0.00585611
|n_genomes=1
|n_genomes_annotated=0
|n_haplomes=1
|n_articles=0
|n_articles_annotated=0
|in_omim=Y
|pph2_score=0.001
|nblosum100=-1
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}